Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1350.20

11.70 (0.87%)

< Home < Back

Dr Reddys Laboratories informs about press release

Date: 28-03-2016

Dr Reddys Laboratories has informed about a press release dated March 28, 2016 titled ‘Dr. Reddy’s Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829’

The above information is a part of company’s filings submitted to BSE.